Table 4 Perception and knowledge of healthcare practitioners on the contributions of antimicrobial compounding to antimicrobial resistance
Statements for perception evaluation | No. = 300, 100% | ||||||
|---|---|---|---|---|---|---|---|
strongly agree | Agree | Neutral | Disagree | Strongly disagree | Don’t know | ||
More cautious use of antimicrobials in extemporaneous formulations would decrease AMR | 93 (31) | 95 (31.7) | 45 (15) | 6 (2) | 21 (7) | 40 (13.3) | |
For extemporaneous compounding, using broad-spectrum antimicrobials can be used in place of narrow-spectrum antimicrobials to reduce resistance | 37 (12.3) | 82 (27.3) | 101 (33.7) | 46 (15.3) | 12 (4) | 22 (7.3) | |
Inappropriate or substandard extemporaneous compounding of antimicrobials contributes to AMR development | 112 (37.3) | 46 (15.3) | 49 (16.3) | 11 (3.7) | 20 (6.7) | 62 (20.7) | |
Statements for knowledge evaluation | No = 300, 100% | ||||||
Factors contribution for AMR development | Under dose administration | 177 (59) | |||||
Contamination | 86 (28.7) | ||||||
Inappropriate preparation process due to lack of standard operating procedures | 225 (75) | ||||||
Ineffectiveness nature of compounded preparation | 47 (15.7) | ||||||
Incompatibility between drug and excipient(s) | 46 (15.3) | ||||||
Using after beyond use date | 44 (14.7) | ||||||
Other (specify) | 2 (0.7) | ||||||